Advancing Eyecare has acquired the ophthalmic instrument distributor Ophthalmic Instruments Inc., according to a press release.Advancing Eyecare, a partnership of eye care instrumentation marketplace leaders that was formed by Atlantic Street Capital w…
Magnetically Controlled Microbots for Drug Delivery and Hyperthermia Therapy in Cancer
Researchers in Daegu Gyeongbuk Institute of Science and Technology in South Korea have developed biodegradable microrobots that can be magnetically controlled to deliver drugs and provide hyperthermia treatment at the site of a tumor. This latest research effort attempts to provide a delivery option for two different therapy pypes by creating biode (Read more...)
FDA, European Medicines Agency advance abicipar pegol applications for wet AMD
The FDA has accepted a biologics license application and the European Medicines Agency has validated a marketing authorization application for abicipar pegol, an investigational DARPin therapy for wet age-related macular degeneration, Allergan and Mole…
Streaming on Android Devices Now Available for Individuals with Hearing Loss
For people with hearing loss, use of a mobile or smartphone can be challenging and with limited options. While Bluetooth-connected hearing aids are available, these solutions impose a significant energy requirement that drains battery life. Most available Bluetooth hearing aids today do not allow users to have access to their mobile device for an e (Read more...)
Sacrificial Ink Writing Technique for 3D Printed Organs
Researchers at Harvard have developed a way to 3D print vascular channels in large matrices composed of stem cell-derived organ building blocks. The technique could pave the way for 3D-printed organs. Creating human organs using 3D printing would help to address the current shortfall in available transplants. However, to date, this has proved to be (Read more...)
ProQR’s retinitis pigmentosa treatment receives fast track designation
The FDA has granted fast track designation to QR-1123, an investigational antisense oligonucleotide, ProQR Therapeutics announced in a press release.QR-1123, designed to treat the underlying causes of vision loss associated with autosomal dominant reti…